Search Results - "Refai FS"

A new class of natural anthelmintics targeting lipid metabolism.

Authors: Fahs HZ Refai FS Gopinadhan S et al.

Source: Nature communications [Nat Commun] 2025 Jan 02; Vol. 16 (1), pp. 305. Date of Electronic Publication: 2025 Jan 02.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Analytical characterization and biological assay of avocado lipids with nematocidal activity.

Authors: Hunashal Y Battaglia G Mohammed Refai FS et al.

Source: Food chemistry [Food Chem] 2025 Nov 01; Vol. 491, pp. 145215. Date of Electronic Publication: 2025 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 7702639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7072 (Electronic) Linking ISSN: 03088146 NLM ISO Abbreviation: Food Chem Subsets: MEDLINE

Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction.

Authors: Zhang, Shizheng Li, Mengmeng Li, Yuan et al.

Source: Journal of Nanobiotechnology. 3/11/2025, Vol. 23 Issue 1, p1-20. 20p.

Rethinking 'rare' PINK1 Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology.

Authors: Yin, Eden Paige Dieriks, Birger Victor

Source: Journal of Parkinson's Disease. Feb2025, Vol. 15 Issue 1, p41-65. 25p.

Role of dopamine in the pathophysiology of Parkinson's disease.

Authors: Zhou, Zhi Dong Yi, Ling Xiao Wang, Dennis Qing et al.

Source: Translational Neurodegeneration. 9/18/2023, Vol. 12 Issue 1, p1-15. 15p.

Investigating the correlation of muscle function tests and sarcomere organization in C. elegans.

Authors: Lesanpezeshki, Leila Qadota, Hiroshi Darabad, Masoud Norouzi et al.

Source: Skeletal Muscle. 8/13/2021, Vol. 11 Issue 1, p1-15. 15p.

Biophysical analysis of drug efficacy on C. elegans models for neurodegenerative and neuromuscular diseases.

Authors: Sofela, Samuel Sahloul, Sarah Song, Yong-Ak

Source: PLoS ONE. 6/11/2021, Vol. 16 Issue 6, p1-16. 16p.

Altered striatal dopamine levels in Parkinson's disease VPS35 D620N mutant transgenic aged mice.

Authors: Vanan, Sarivin Zeng, Xiaoxia Chia, Sook Yoong et al.

Source: Molecular Brain. 12/1/2020, Vol. 13 Issue 1, pN.PAG-N.PAG. 1p.

Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation.

Authors: Sangbin Lim Smith, Kelly R. Ssang-Taek Steve Lim et al.

Source: Cell & Bioscience. 4/14/2016, Vol. 6, p1-15. 15p.

Platelet-derived biomimetic nanoplatforms: a promising drug delivery strategy for cardiovascular disease.

Authors: Zhang S Han M Li S et al.

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2025 Oct 21; Vol. 23 (1), pp. 687. Date of Electronic Publication: 2025 Oct 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease.

Authors: Henderson, Michael X. Sengupta, Medha Trojanowski, John Q. et al.

Source: Acta Neuropathologica Communications. 11/16/2019, Vol. 7 Issue 1, pN.PAG-N.PAG. 1p.

Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.

Authors: Jensen NM Vitic Z Antorini MR et al.

Source: Acta neuropathologica [Acta Neuropathol] 2025 May 02; Vol. 149 (1), pp. 41. Date of Electronic Publication: 2025 May 02.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Evaluating LRRK2 genetic variants with unclear pathogenicity.

Authors: Refai FS Ng SH Tan EK

Source: BioMed research international [Biomed Res Int] 2015; Vol. 2015, pp. 678701. Date of Electronic Publication: 2015 Mar 02.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101600173 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease.

Authors: Smith LJ Lee CY Menozzi E et al.

Source: Frontiers in neurology [Front Neurol] 2022 Aug 12; Vol. 13, pp. 971252. Date of Electronic Publication: 2022 Aug 12 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk.

Authors: Lake J Reed X Langston RG et al.

Corporate Authors: Lake J Reed X Langston RG et al.

Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Jan; Vol. 37 (1), pp. 95-105. Date of Electronic Publication: 2021 Sep 20.

Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

Gene therapy targeting mitochondrial pathway in Parkinson's disease.

Authors: Choong CJ Mochizuki H

Source: Journal of neural transmission (Vienna, Austria : 1996) [J Neural Transm (Vienna)] 2017 Feb; Vol. 124 (2), pp. 193-207. Date of Electronic Publication: 2016 Sep 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Austria NLM ID: 9702341 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-1463 (Electronic) Linking ISSN: 03009564 NLM ISO Abbreviation: J Neural Transm (Vienna) Subsets: MEDLINE

Ultrasound-based motion analysis demonstrates bilateral arm hypokinesia during gait in heterozygous PINK1 mutation carriers.

Authors: Nürnberger L Klein C Baudrexel S et al.

Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2015 Mar; Vol. 30 (3), pp. 386-92. Date of Electronic Publication: 2014 Dec 27.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.

Authors: Zare K Eidi A Roghani M et al.

Source: Metabolic brain disease [Metab Brain Dis] 2015 Feb; Vol. 30 (1), pp. 205-13. Date of Electronic Publication: 2014 Aug 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8610370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7365 (Electronic) Linking ISSN: 08857490 NLM ISO Abbreviation: Metab Brain Dis Subsets: MEDLINE